Full Text View
Tabular View
No Study Results Posted
Related Studies
Prehospital CPAP vs. Usual Care for Acute Respiratory Failure
This study has been completed.

First Received on November 29, 2006.   No Changes Posted
Sponsor: Dalhousie University
Collaborator: Capital District Health Authority, Canada
Information provided by: Dalhousie University
ClinicalTrials.gov Identifier: NCT00405314
  Purpose

The purpose of this study is to evaluate the effectiveness of continuous positive airway pressure ventilation when applied by paramedics to individuals with severe breathing difficulties in the prehospital setting.


Condition Intervention
Respiratory Insufficiency
Hypoxia
Device: Continuous positive airway pressure ventilation mask

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Prehospital CPAP Versus Usual Care for Acute Respiratory Failure: a Randomized Controlled Trial

Further study details as provided by Dalhousie University:

Primary Outcome Measures:
  • proportion of patients in each group endotracheally intubated prior to hospital discharge or death

Secondary Outcome Measures:
  • mortality
  • critical care unit length of stay
  • hospital length of stay

Estimated Enrollment: 60
Study Start Date: July 2002
Estimated Study Completion Date: March 2006
Detailed Description:

Continuous positive airway pressure ventilation (CPAP) has been shown to be effective in avoiding endotracheal intubation (ETI) for patients with acute respiratory failure in hospital but despite several case series, the effectiveness of the prehospital application of CPAP by paramedics has not been studied in a randomized fashion. We performed a prospective, randomized, non blinded trial to determine whether patients in acute respiratory failure treated with CPAP in the prehospital setting had lower overall ETI rates than those treated with standard care.

  Eligibility

Ages Eligible for Study:   16 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • severe dyspnea
  • respiratory rate >25 breaths/minute
  • hemodynamically stable
  • able to cooperate with ventilatory support measures
  • assessed by paramedics as being in urgent need of ETI and/or manual positive pressure ventilation
  • a trip destination of the QEII Health Sciences Center or Dartmouth General Hospital

Exclusion Criteria:

  • require ETI for immediate airway protection
  • respiratory rate < 8 breaths/minute
  • evidence of hemodynamic instability
  • cardiac ischemia
  • any chest pain within 3 hours of presentation
  • valid “do not resuscitate” advanced directive
  • an inadequate supply of portable oxygen
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00405314

Locations
Canada, Nova Scotia
Dalhousie University
Halifax, Nova Scotia, Canada, B3H 1V7
Sponsors and Collaborators
Dalhousie University
Capital District Health Authority, Canada
Investigators
Principal Investigator: James Thompson, MD University of British Columbia
  More Information

Publications:
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
ClinicalTrials.gov Identifier: NCT00405314     History of Changes
Other Study ID Numbers: DAL06-04
Study First Received: November 29, 2006
Last Updated: November 29, 2006
Health Authority: Canada: Ethics Review Committee

Keywords provided by Dalhousie University:
respiratory failure
non invasive ventilation
prehospital
endotracheal intubation
continuous positive airway pressure

Additional relevant MeSH terms:
Respiratory Insufficiency
Anoxia
Respiratory Distress Syndrome, Adult
Respiration Disorders
Respiratory Tract Diseases
Signs and Symptoms, Respiratory
Signs and Symptoms
Lung Diseases

ClinicalTrials.gov processed this record on February 09, 2012